|

Mesothelin and Claudin 18.2 CAR-T cells Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Essen Biotech1

Indications

  • Pancreatic Cancer Non-resectable1
  • Pancreatic Cancer Stage IV1
  • Pancreatic Cancer1
  • Pancreatic Carcinoma1
  • Cancer1

Other1 trial

Mesothelin and Claudin 18.2 Dual-Target CAR-T Therapy in Advanced Pancreatic Cancer
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.